Study2016

Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults

Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N

Progress in lipid research · 359 citations

Review labels

Ancestral / evolutionaryFunding not disclosed

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Systematic review (classified by our AI screen)
Studied in
People
Main outcome
No health outcome
Lens
Ancestral or evolutionary evidence

Who paid for it

Funding
Funding not disclosed

Publication

Published
2016-05-22 · Prog Lipid Res · vol. 63 · pp. 132–152
Publisher
Elsevier BV
Cited
529 citations · more than 100% of similar papers · 36.7× the field average
Impact
Top 10% most cited in its field
References
604 works
Access
Open access (hybrid journal) · CC-BY
Research areas
Fatty Acid Research and Health · Lipid metabolism and biosynthesis · Alcohol Consumption and Health Effects
Keywords
Docosahexaenoic acid, Eicosapentaenoic acid, Polyunsaturated fatty acid, Blood lipids, Fatty acid, Whole blood, Chemistry, Internal medicine, Biology, Food science, Biochemistry, Physiology, Medicine, Cholesterol
MeSH
erythrocytes, humans, fatty acids, omega-3, docosahexaenoic acids, eicosapentaenoic acid, fatty acids, dietary supplements, databases, factual, biomarkers

5 authors

From CA, US, CH, NL

  • Ken D. Stark · correspondingUniversity of Waterloo
  • Mary E. Van Elswyk
  • Marguerite HigginsClinical Research Associates
  • Charli A WeatherfordWeatherford (Switzerland); Weatherford (United States)
  • Norman SalemDSM (Netherlands); Nutrition 21 (United States)

Abstract

Studies reporting blood levels of the omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), were systematically identified in order to create a global map identifying countries and regions with different blood levels. Included studies were those of healthy adults, published in 1980 or later. A total of 298 studies met all inclusion criteria. Studies reported fatty acids in various blood fractions including plasma total lipids (33%), plasma phospholipid (32%), erythrocytes (32%) and whole blood (3.0%). Fatty acid data from each blood fraction were converted to relative weight percentages (wt.%) and then assigned to one of four discrete ranges (high, moderate, low, very low) corresponding to wt.% EPA+DHA in erythrocyte equivalents. Regions with high EPA+DHA blood levels (>8%) included the Sea of Japan, Scandinavia, and areas with indigenous populations or populations not fully adapted to Westernized food habits. Very low blood levels (≤4%) were observed in North America, Central and South America, Europe, the Middle East, Southeast Asia, and Africa. The present review reveals considerable variability in blood levels of EPA+DHA and the very low to low range of blood EPA+DHA for most of the world may increase global risk for chronic disease.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.